Author: Jasmine Smith

To say the medical field is large is an understatement. The valuation of the global healthcare industry’s stands at a staggering $12 trillion today. Over the past decade, medical research has expanded significantly and remains a substantial area for investment. Nevertheless, allocating this funding is not always straightforward or easy. The primary obstacle is the neglect and insufficient financial support for treatments of numerous sectors within the medical realm. This is because treatment funding is, understandably, often focused quite heavily on a select number of diseases, primarily the ones that impact higher numbers within a population. Heart disease or COVID-19…